Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2

Breast cancer is the most common female cancer in the world. Despite the active research on metastatic breast cancer, the treatment of breast cancer patients is still difficult because the mechanism is not well known. Therefore, research on new targets and mechanisms for diagnosis and treatment of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Seok, Hyun Jeong, Choi, Young Eun, Choi, Jae Yeon, Yi, Joo Mi, Kim, Eun Joo, Choi, Mi Young, Lee, Su-Jae, Bae, In Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365326/
https://www.ncbi.nlm.nih.gov/pubmed/34457998
http://dx.doi.org/10.1016/j.omtn.2021.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365326/
https://www.ncbi.nlm.nih.gov/pubmed/34457998
http://dx.doi.org/10.1016/j.omtn.2021.05.004

Ejemplares similares